AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Viagra clinical studies in women do not support regulatory filing.

Women's Health Weekly

| April 01, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 APR 1 - (NewsRx.com & NewsRx.net) -- Pfizer Inc said that results from clinical studies investigating the use of Viagra (sildenafil citrate) as a treatment for female sexual arousal disorder (FSAD) do not support a regulatory filing.

Pfizer began its FSAD research program in 1996. To date the company has conducted several large-scale placebo-controlled studies involving approximately 3,000 women. While Viagra was found to be safe in all studies, efficacy data were inconclusive. Pfizer said the program would draw to a close this month.

A highly prevalent condition with a major impact on quality of life, FSAD is a complex constellation of symptoms that are difficult to identify, measure and treat. The American Foundation for Urological Diseases defines FSAD as a persistent inability to attain or maintain sufficient sexual excitement that causes personal distress.

The condition, which may occur alone or in conjunction with other female sexual disorders, is believed to result from a broad range of medical and psychological conditions.

"FSAD is an emerging area of research and is far more complex than male erectile dysfunction," said Dr. Joe Feczko, president of worldwide development at Pfizer. "Diagnosing FSAD involves assessing physical, emotional, and relationship factors, and these complex and interdependent factors make measuring a medicine's effect very difficult."

Pfizer discovered and over the next ...

Related articles from newspapers, magazines, journals, and more
National Congressional Leaders and Pfizer Join Community Health Centers of...
Magazine article from: Women's Health Weekly August 21, 2008 700+ words
...Gary Pelletier, director of Pfizer Helpful Answers(R). Last year, Pfizer distributed more than $2...Disease, Community Health, Pfizer, Pharmaceutical Business...was prepared by Women's Health Weekly editors from staff and other...
CHASS Center, Inc. and Pfizer Honor Health Care Heroes.
Magazine article from: Women's Health Weekly August 28, 2008 700+ words
...849-3920 ext. 294. "Pfizer is dedicated to supporting...Gary Pelletier, director of Pfizer Helpful Answers(R). "Today...Keywords: Community Health, Pfizer, Pharmaceutical Business...article was prepared by Women's Health Weekly editors from staff and other...
Congressman Raul Grijalva Joins Local Health Center and Pfizer to Honor...
Magazine article from: Women's Health Weekly September 4, 2008 700+ words
...or call 928-539-3085. "Pfizer is dedicated to supporting...Gary Pelletier, director of Pfizer Helpful Answers(R). "Tomorrow...Keywords: Community Health, Pfizer, Pharmaceutical Business...article was prepared by Women's Health Weekly editors from staff and other...
Pfizer to end tests of Viagra for women.
Magazine article from: Women's Health Weekly March 18, 2004 700+ words
...president of Worldwide Developing at Pfizer, said diagnosing sexual difficulties...prescribed Viagra since then, Pfizer said. Pfizer said it began studying whether...article was prepared by Women's Health Weekly editors from staff and other reports...
Pfizer Receives FDA Complete Response Letter for Lasofoxifene.
Magazine article from: Women's Health Weekly February 5, 2009 700+ words
...the companyEs application. Pfizer submitted the current application...advice of the panel. Keywords: Pfizer Inc, FDA, Osteoporosis, Pfizer, Pharmaceutical Business...article was prepared by Women's Health Weekly editors from staff and other...
Inverness to supply Pfizer with a digital version of its e.p.t pregnancy test.
Magazine article from: Women's Health Weekly January 15, 2004 700+ words
...previously entered into with Pfizer, Inverness has agreed to supply Pfizer with its requirements for...minimum purchase obligations. Pfizer's purchases of digital pregnancy...was prepared by Women's Health Weekly editors from staff and other...
Acquisition of women's healthcare products considered.(Galen Holdings PLC and...
Magazine article from: Women's Health Weekly April 3, 2003 700+ words
...Sarafem acquisition and the Pfizer product acquisitions, is anticipated...with further details of the Pfizer products and the acquisitions...prior to its acquisition by Pfizer in June 2000. During my time...article was prepared by Women's Health Weekly editors from staff and other...
New pharmacology study results from Pfizer Inc. described.(Report)
Magazine article from: Women's Health Weekly November 27, 2008 700+ words
...information, contact N. Pullen, Pfizer PGRD, Ramsgate Rd., Sandwich...Gynecology, Mifepristone, Pfizer, Pharmaceutical Business...Therapy, Treatment, Pfizer Inc. This article was prepared by Women's Health Weekly editors from staff and other...
New life sciences findings from Pfizer Inc. described.(Clinical report)
Magazine article from: Women's Health Weekly June 25, 2009 700+ words
...E. Bove and colleagues, Pfizer Inc. The researchers concluded...by contacting S.E. Bove, Pfizer Global Research and Development...Treatment, Pharmaceuticals, Pfizer, Pharmaceutical Business...article was prepared by Women's Health Weekly editors from staff and other...
Charter Hospital Closings May Signal Bigger Problems Ahead, Reports Mental...
Press release article from: PR Newswire February 14, 2000 700+ words
...reports this week's issue of Mental Health Weekly. The stark numbers include 33 hospital...Karen Keiser-Jenkins told Mental Health Weekly last week. Keiser-Jenkins says the...Newswire. For more information on Mental Health Weekly, click on "Newsletters" to receive...
For more facts and information, see all results

Source: HighBeam Research, Viagra clinical studies in women do not support regulatory filing.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA